Protagenic Therapeutics, Inc. is a biotechnology company, which specializes in the discovery and development of therapeutics to treat central nervous system disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.
$5.82 OTCQB
As of 04/09/2021 OTCMarkets
2021 © Stock Market MBA, Inc.